Quantib® ND
Quantib
Product specifications |
Information source:
Vendor
Last updated: March 19, 2023 |
General | |
---|---|
Product name | Quantib® ND |
Company | Quantib |
Subspeciality | Neuro |
Modality | MR |
Disease targeted | Neurodegenerative disease, dementia, Alzheimer’s disease, multiple sclerosis |
Key-features | Brain structure segmentation and volume quantification, multiple time-point analysis, white matter hyperintensity detection and quantification, comparison to reference population |
Suggested use | During: interactive decision support (shows abnormalities/results only on demand), report suggestion |
Data characteristics | |
Population | All with suspicion of neuro degenerative disease, dementia, Alzheimer’s disease, MS |
Input | (contrast) 3DT1 MRI, (contrast) 3D or 2D T2 FLAIR MRI |
Input format | DICOM |
Output | segmentation overlays, draft radiology report including normative comparison |
Output format | DICOM |
Technology | |
Integration | Integration via AI marketplace or distribution platform, Stand-alone third party application |
Deployment | Locally on dedicated hardware |
Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | > 10 minutes |
Certification | |
CE
|
Certified,
Class IIa
, MDR
|
FDA
|
510(k) cleared, Class II |
Market presence | |
On market since | 09-2017 |
Distribution channels | Nuance |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | Subscription |
Based on | Number of users, Number of installations |
Evidence | |
Peer reviewed papers on performance |
|
Non-peer reviewed papers on performance | |
Other relevant papers |